Quality Level
product line
TraceCERT®
grade
certified reference material, TraceCERT®
CofA
current certificate can be downloaded
packaging
ampule of 1 mL
concentration
5000 μg/mL in methanol
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
environmental
format
single component solution
storage temp.
2-8°C
SMILES string
N(c2ccccc2)c1ccccc1
InChI
1S/C12H11N/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h1-10,13H
InChI key
DMBHHRLKUKUOEG-UHFFFAOYSA-N
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Other Notes
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Legal Information
TraceCERT is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 3 - Flam. Liq. 2 - STOT SE 1
target_organs
Eyes,Central nervous system
저장 등급
3 - Flammable liquids
wgk
WGK 2
flash_point_f
51.8 °F - closed cup
flash_point_c
11 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
Jonathan N King et al.
American journal of veterinary research, 74(3), 465-472 (2013-02-27)
To establish pharmacokinetics of robenacoxib after administration to cats via the IV, SC, and oral routes. 24 cats. In a crossover design, robenacoxib was administered IV, SC, and orally (experiment 1) and orally (experiment 2) to cats with different feeding
Kellie Hom et al.
Journal of medicinal chemistry, 56(5), 2097-2109 (2013-02-06)
Bacteria require iron for survival and virulence and employ several mechanisms including utilization of the host heme containing proteins. The final step in releasing iron is the oxidative cleavage of heme by HemO. A recent computer aided drug design (CADD)
John G Albeck et al.
Molecular cell, 49(2), 249-261 (2012-12-12)
The EGF-stimulated ERK/MAPK pathway is a key conduit for cellular proliferation signals and a therapeutic target in many cancers. Here, we characterize two central quantitative aspects of this pathway: the mechanism by which signal strength is encoded and the response